Mehta Arpan R, Mehta Puja R, Mehta Rajesh L
Oxford University Hospitals NHS Trust, Oxford, UK.
BMJ Case Rep. 2012 Oct 24;2012:bcr2012007327. doi: 10.1136/bcr-2012-007327.
We describe a non-smoker who presented with a persistent cough, weight loss and general malaise, and had a medical history of bladder carcinoma that had been successfully treated with intravesical BCG immunotherapy. Radiology revealed hilar lymphadenopathy, a predominantly mid-zone and lower-zone lung parenchymal nodular pattern with a perilymphatic distribution, a few thickened interlobular septae, and small pleural effusions bilaterally. The T-SPOT.TB blood test was negative. Video-assisted thoracoscopic surgery showed multiple pleural nodules, the histopathology of which showed multiple well-defined non-caseating granulomata. The patient was started on antituberculosis medication for presumed BCGosis--a systemic complication of previous BCG immunotherapy--and the patient showed an excellent clinical and radiological response. This case further adds to previous reports and reinforces the recommendation that all patients should be made fully aware of the potential systemic and delayed complications of BCG immunotherapy when they are consented for treatment.
我们描述了一名不吸烟者,其表现为持续咳嗽、体重减轻和全身不适,有膀胱癌病史,曾成功接受膀胱内卡介苗免疫治疗。放射学检查显示肺门淋巴结肿大,主要为中肺野和下肺野肺实质结节状,呈淋巴管周围分布,少数小叶间隔增厚,双侧少量胸腔积液。结核感染T细胞检测(T-SPOT.TB)血液检查结果为阴性。电视辅助胸腔镜手术显示多个胸膜结节,其组织病理学显示多个边界清晰的非干酪样肉芽肿。该患者因推测为卡介苗病(既往卡介苗免疫治疗的一种全身并发症)而开始接受抗结核药物治疗,患者在临床和放射学方面均显示出良好的反应。该病例进一步补充了既往报道,并强化了一项建议,即在患者同意接受治疗时,应让所有患者充分了解卡介苗免疫治疗潜在的全身和延迟并发症。